Product Overview
ID Components Size (96 tests)
ISK-012-1 High-bind Plate 1 plate
ISK-012-2 Human PD-L2 50 μg
ISK-012-3 Biotinylated Human PD-1 10 μg
ISK-012-4 Anti-PD-1 Neutralizing Antibody 20 μg
ISK-012-5 Streptavidin-HRP 10 μg
ISK-012-6 Coating Buffer 12 mL
ISK-012-7 10xWashing Buffer 50 mL
ISK-012-8 Blocking Buffer 50 mL
ISK-012-9 Substrate Solution 24 mL
ISK-012-10 Stop Solution 7 mL
Description
PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells.
Assay Principles
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new PD-1 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human PD-1 to immobilized human PD-L2 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinlated PD-1 protein, a human PD-L2 protein, an anti-PD-1 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with human PD-L2.
b) Add your molecule of interest to the tests.
c) Add human PD-1-Biotin to bind the coated human PD-L2.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
Finally, the half maximal inhibitory concentration (IC50) of your compound to PD-L2: PD-1 binding will be determined by comparing OD readings among different experimental groups.